Novel therapies for inflammatory bowel disease

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Recent advances in our understanding of the basic processes that contribute to inflammatory bowel disease have led to the identification of new targets for therapy. Novel therapies, which include agents in development and those newly introduced for use in the clinic, include both traditional compounds and a growing number of biologic response modifiers. This article places these novel therapies within a pathophysiologic framework, highlighting completely new targets and therapeutic modalities.

Original languageEnglish
Pages (from-to)323-351
Number of pages29
JournalGastroenterology Clinics of North America
Issue number2
StatePublished - 1999
Externally publishedYes


Dive into the research topics of 'Novel therapies for inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this